Literature DB >> 6705321

Systemic Candida albicans infection with cerebral abscess and granulomas.

H Wiethölter, A Thron, E Scholz, J Dichgans.   

Abstract

This study reports the case of a 19-year-old Turkish woman who was suffering from a cerebral abscess and granuloma formation caused by Candida albicans. The diagnosis of her illness was established by cytologic analysis of the cerebrospinal fluid. Combined application of amphotericin B and 5-fluorocytosine cured the patient's disorder. Its remission was documented over a period of 2 years by the use of computed tomography.

Entities:  

Mesh：

Substances：

Year:  1984        PMID： 6705321

Source DB:  PubMed          Journal:  Clin Neuropathol        ISSN： 0722-5091            Impact factor:   1.368


  3 in total

1.  Inherited CARD9 deficiency in otherwise healthy children and adults with Candida species-induced meningoencephalitis, colitis, or both.

Authors:  Fanny Lanternier; Seyed Alireza Mahdaviani; Elisa Barbati; Hélène Chaussade; Yatrika Koumar; Romain Levy; Blandine Denis; Anne-Sophie Brunel; Sophie Martin; Michèle Loop; Julie Peeters; Ariel de Selys; Jean Vanclaire; Christiane Vermylen; Marie-Cécile Nassogne; Olga Chatzis; Luyan Liu; Mélanie Migaud; Vincent Pedergnana; Guillaume Desoubeaux; Gregory Jouvion; Fabrice Chretien; Ilad Alavi Darazam; Alejandro A Schäffer; Mihai G Netea; Jean J De Bruycker; Louis Bernard; Jacques Reynes; Noureddine Amazrine; Laurent Abel; Dimitri Van der Linden; Tom Harrison; Capucine Picard; Olivier Lortholary; Davood Mansouri; Jean-Laurent Casanova; Anne Puel
Journal:  J Allergy Clin Immunol       Date:  2015-02-19       Impact factor: 10.793

2.  Candida albicans brain abscesses in an injection drug user patient: a case report.

Authors:  Nélia Neves; Lurdes Santos; Carina Reis; António Sarmento
Journal:  BMC Res Notes       Date:  2014-11-25

3.  Multiple brain abscesses caused by infection with Candida glabrata: A case report.

Authors:  Zifeng Zhu; Zhehao Huang; Zhenshengnan Li; Xianglan Li; Chao Du; Yu Tian
Journal:  Exp Ther Med       Date:  2018-01-04       Impact factor: 2.447
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.